RESMED INC — Director's Dealing 2022

Jun 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-06-03

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-03	ResMed Common Stock	S	1545	$209.44	Disposed	108376	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: Includes 62.7151 shares of ResMed stock purchased on April 29, 2022, through the ResMed Employee Stock Purchase Plan.